MIGLUSTAT Pharmacologic Class Indexing
- Class set ID
- 61162db0-2ff8-4de0-88d1-df230f6b060d
- Version
- 3
- Effective date
- 20240306
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval:2003 | Navinta LLC | 20251231 | 3 |
| These highlights do not include all the information needed to use YARGESA safely and effectively. See full prescribing information for YARGESA. YARGESA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | Edenbridge Pharmaceuticals LLC. | 20251217 | 5 |
| These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval: 2003 | ANI Pharmaceuticals, Inc. | 20251126 | 7 |
| These highlights do not include all the information needed to use MIGLUSTAT CAPSULES safely and effectively. See full prescribing information for MIGLUSTAT CAPSULES. MIGLUSTAT capsules, for oral use Initial U.S. Approval: 2003 | Zydus Pharmaceuticals USA Inc. | Navinta LLC | 20250317 | 1 |
| These highlights do not include all the information needed to use OPFOLDA ® safely and effectively. See full prescribing information for OPFOLDA. OPFOLDA (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | AMICUS THERAPEUTICS US, LLC | 20241127 | 5 |
| These highlights do not include all the information needed to use miglustat safely and effectively. See full prescribing information for miglustat. miglustat capsules, for oral use Initial U.S. Approval: 2003 | CoTherix, Inc. | Almac Pharma Services Ltd. | Lonza AG | 20230425 | 16 |
| These highlights do not include all the information needed to use ZAVESCA safely and effectively. See full prescribing information for ZAVESCA. ZAVESCA ® (miglustat) capsules, for oral use Initial U.S. Approval: 2003 | Actelion Pharmaceuticals US, Inc. | Almac Pharma Services Limited | Lonza AG | 20230420 | 19 |
| Miglustat (4237.G) | Veranova, L.P. | 20221109 | 3 |